{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:02:16Z","timestamp":1793239336030,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.berh.2024.101971","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T07:55:05Z","timestamp":1721030105000},"page":"101971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Exploring the contribution of genetics on the clinical manifestations of systemic lupus erythematosus"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0711-8373","authenticated-orcid":false,"given":"Ruth D.","family":"Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta E.","family":"Alarc\u00f3n-Riquelme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.berh.2024.101971_bib1","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1002\/art.34650","article-title":"Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian\u2013European populations","volume":"64","author":"S\u00e1nchez","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.berh.2024.101971_bib2","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"EULAR\/ACR classification Criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"6","key":"10.1016\/j.berh.2024.101971_bib3","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.101971_bib4","series-title":"Systemic lupus erythematosus","first-page":"317","article-title":"Chapter 37 - constitutional symptoms and fatigue in systemic lupus erythematosus","author":"Shaharir","year":"2016"},{"issue":"17","key":"10.1016\/j.berh.2024.101971_bib5","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.3390\/jcm10173996","article-title":"Fatigue in systemic lupus erythematosus: an update on its impact, determinants and Therapeutic management","volume":"10","author":"Kawka","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.berh.2024.101971_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2012.10.010","article-title":"Tyrosine metabolism during interferon-alpha Administration: association with fatigue and CSF dopamine concentrations","volume":"31","author":"Felger","year":"2013","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.berh.2024.101971_bib7","first-page":"62","article-title":"Noninfectious causes of fever in 128 patients with systemic lupus erythematosus","volume":"48","author":"Guo","year":"2019","journal-title":"Iran J Public Health"},{"issue":"4","key":"10.1016\/j.berh.2024.101971_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41584-023-00925-5","article-title":"Treatment of lupus nephritis: consensus, evidence and perspectives","volume":"19","author":"Mok","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2024.101971_bib9","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.05780616","article-title":"Update on lupus nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"suppl_1","key":"10.1016\/j.berh.2024.101971_bib10","first-page":"i67","article-title":"The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus","volume":"56","author":"Lewis","year":"2017","journal-title":"Rheumatol Oxf Engl"},{"issue":"2","key":"10.1016\/j.berh.2024.101971_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/acr.24431","article-title":"Systemic lupus erythematosus: Targeted Literature review of the epidemiology, current treatment, and disease burden in the asia pacific region","volume":"74","author":"Tanaka","year":"2022","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.berh.2024.101971_bib12","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/art.39504","article-title":"Genome-wide association study in an amerindian ancestry population reveals novel systemic lupus erythematosus risk loci and the role of European admixture","volume":"68","author":"Ziegler","year":"2016","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"4","key":"10.1016\/j.berh.2024.101971_bib13","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/art.39504","article-title":"GWAS in an Amerindian ancestry population reveals novel systemic lupus erythematosus risk loci and the role of European admixture","volume":"68","author":"Alarc\u00f3n-Riquelme","year":"2016","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"1","key":"10.1016\/j.berh.2024.101971_bib14","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1038\/ncomms6902","article-title":"The HLA-DR\u03b21 amino acid positions 11\u201313\u201326 explain the majority of SLE\u2013MHC associations","volume":"5","author":"Kim","year":"2014","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.berh.2024.101971_bib15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/ng.3496","article-title":"High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry","volume":"48","author":"Sun","year":"2016","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.berh.2024.101971_bib16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1744-313X.2012.01145.x","article-title":"The genetic contribution of HLA-DRB5*01:01 to systemic lupus erythematosus in Thailand","volume":"40","author":"Louthrenoo","year":"2013","journal-title":"Int J Immunogenet"},{"issue":"11","key":"10.1016\/j.berh.2024.101971_bib17","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1681\/ASN.2016121331","article-title":"Association analysis of the MHC in lupus nephritis","volume":"28","author":"Xu","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.berh.2024.101971_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/1756-185X.12528","article-title":"Value of HLA-DR genotype in systemic lupus erythematosus and lupus nephritis: a meta-analysis","volume":"18","author":"Niu","year":"2015","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2024.101971_bib19","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1038\/s41467-021-23361-z","article-title":"Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus","volume":"12","author":"Hasni","year":"2021","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.berh.2024.101971_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084450","article-title":"Association of STAT4 polymorphism with severe renal insufficiency in lupus nephritis","volume":"8","author":"Bolin","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.berh.2024.101971_bib21","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/annrheumdis-2020-219727","article-title":"Interaction between the STAT4 rs11889341(T) risk allele and smoking confers increased risk of myocardial infarction and nephritis in patients with systemic lupus erythematosus","volume":"80","author":"Reid","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2024.101971_bib22","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/art.42435","article-title":"Down-regulation\u2013resistant STAT4 risk haplotype contributes to lupus nephritis through CD4+ T cell interferon-\u03b3 production","volume":"75","author":"Madera-Salcedo","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.berh.2024.101971_bib23","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/annrheumdis-2017-212794","article-title":"The STAT4 SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-\u03b3 production in T cells from patients with SLE","volume":"77","author":"Hagberg","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2024.101971_bib24","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.4049\/jimmunol.1700608","article-title":"The ox40\/ox40 ligand pathway promotes pathogenic Th cell responses, plasmablast accumulation, and lupus nephritis in NZB\/W F1 mice","volume":"199","author":"Sitrin","year":"2017","journal-title":"J Immunol Author Choice."},{"issue":"10","key":"10.1016\/j.berh.2024.101971_bib25","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1136\/ard.2011.154104","article-title":"Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus","volume":"70","author":"Sanchez","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.101971_bib26","article-title":"A replication study from Chinese supports association between lupus-risk allele in TNFSF4 and renal disorder","volume":"2013","author":"jie","year":"2013","journal-title":"BioMed Res Int"},{"issue":"3","key":"10.1016\/j.berh.2024.101971_bib27","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10067-020-05332-9","article-title":"TNFSF4 is a risk factor to systemic lupus erythematosus in a Latin American population","volume":"40","author":"Moreno-Eutimio","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2024.101971_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/0256-4947.75775","article-title":"OX40\/OX40L in systemic lupus erythematosus: association with disease activity and lupus nephritis","volume":"31","author":"Farres","year":"2011","journal-title":"Ann Saudi Med"},{"issue":"2","key":"10.1016\/j.berh.2024.101971_bib29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2249.2006.03141.x","article-title":"CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus","volume":"145","author":"Patschan","year":"2006","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.berh.2024.101971_bib30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/annrheumdis-2011-200085","article-title":"Genetic and physical interaction of the B-cell systemic lupus erythematosus-associated genes BANK1 and BLK","volume":"71","author":"Castillejo-L\u00f3pez","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2024.101971_bib31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ng.81","article-title":"Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci","volume":"40","author":"Harley","year":"2008","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.berh.2024.101971_bib32","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1038\/s41467-019-10242-9","article-title":"Functional rare and low frequency variants in BLK and BANK1 contribute to human lupus","volume":"10","author":"Jiang","year":"2019","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.berh.2024.101971_bib33","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s10038-020-0756-4","article-title":"Polymorphisms of BLK are associated with renal disorder in patients with systemic lupus erythematosus","volume":"65","author":"Di","year":"2020","journal-title":"J Hum Genet"},{"issue":"2","key":"10.1016\/j.berh.2024.101971_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/ng.79","article-title":"Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus","volume":"40","author":"Kozyrev","year":"2008","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.berh.2024.101971_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156302","article-title":"BANK1 regulates IgG production in a lupus model by controlling TLR7-dependent STAT1 activation","volume":"11","author":"Wu","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.berh.2024.101971_bib36","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41423-019-0254-9","article-title":"BANK1 interacts with TRAF6 and MyD88 in innate immune signaling in B cells","volume":"17","author":"Georg","year":"2020","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"10.1016\/j.berh.2024.101971_bib37","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.3390\/ijms19082331","article-title":"Trans-ethnic mapping of BANK1 identifies two independent SLE-risk linkage groups enriched for Co-transcriptional splicing marks","volume":"19","author":"Mart\u00ednez-Bueno","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.berh.2024.101971_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms16021","article-title":"Transancestral mapping and genetic load in systemic lupus erythematosus","volume":"8","author":"Langefeld","year":"2017","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.berh.2024.101971_bib39","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41435-021-00142-8","article-title":"Variants in BANK1 are associated with lupus nephritis of European ancestry","volume":"22","author":"Bolin","year":"2021","journal-title":"Gene Immun"},{"issue":"5","key":"10.1016\/j.berh.2024.101971_bib40","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3390\/genes14051105","article-title":"ITGAM rs1143679 variant in systemic lupus erythematosus is associated with increased serum calcification propensity","volume":"14","author":"Halfon","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.berh.2024.101971_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.trsl.2022.03.001","article-title":"CD11b agonists offer a novel approach for treating lupus nephritis","volume":"245","author":"Villanueva","year":"2022","journal-title":"Transl Res"},{"issue":"4","key":"10.1016\/j.berh.2024.101971_bib42","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.autrev.2011.07.007","article-title":"Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases","volume":"11","author":"Anaya","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.berh.2024.101971_bib43","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1136\/annrheumdis-2012-201390","article-title":"The rs1143679 (R77H) lupus associated variant of ITGAM (CD11b) impairs complement receptor 3 mediated functions in human monocytes","volume":"71","author":"Rhodes","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2024.101971_bib44","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41397-023-00308-9","article-title":"Association between functional FCGR3A F158V and FCGR2A R131H polymorphisms and responsiveness to rituximab in patients with autoimmune diseases: a meta-analysis","volume":"23","author":"Lee","year":"2023","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"10.1016\/j.berh.2024.101971_bib45","first-page":"1463","article-title":"Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional hFc gamma RIIa polymorphism to IgG2","volume":"151","author":"Bredius","year":"1950","journal-title":"J Immunol Baltim Md"},{"issue":"2","key":"10.1016\/j.berh.2024.101971_bib46","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/art.10930","article-title":"Identification of IgG subclasses and C-reactive protein in lupus nephritis: the relationship between the composition of immune deposits and FCgamma receptor type IIA alleles","volume":"48","author":"Zuniga","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.101971_bib47","series-title":"Systemic lupus erythematosus (SLE)","article-title":"B cell activating factor (BAFF): structure, functions, autoimmunity and clinical implications","author":"M\u00f6ckel","year":"2021"},{"issue":"4","key":"10.1016\/j.berh.2024.101971_bib48","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1046\/j.1523-1755.2003.00873.x","article-title":"The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis","volume":"63","author":"Karassa","year":"2003","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.berh.2024.101971_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030396","article-title":"Time to renal disease and end-stage renal disease in profile: a multiethnic lupus cohort","volume":"3","author":"Alarc\u00f3n","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.berh.2024.101971_bib50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clim.2016.09.012","article-title":"Genetics of human lupus nephritis","volume":"185","author":"Iwamoto","year":"2017","journal-title":"Clin Immunol"},{"issue":"12","key":"10.1016\/j.berh.2024.101971_bib51","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/ng.3434","article-title":"Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus","volume":"47","author":"Bentham","year":"2015","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.berh.2024.101971_bib52","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ng1782","article-title":"A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus","volume":"38","author":"Graham","year":"2006","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.berh.2024.101971_bib53","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00439-007-0367-6","article-title":"Genetic association of IRF5 with SLE in Mexicans: higher frequency of the risk haplotype and its homozygozity than Europeans","volume":"121","author":"Reddy","year":"2007","journal-title":"Hum Genet"},{"issue":"2","key":"10.1016\/j.berh.2024.101971_bib54","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/hmg\/ddu455","article-title":"The IRF5\u2013TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share","volume":"24","author":"Kottyan","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.berh.2024.101971_bib55","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1177\/0961203316686845","article-title":"Interferon regulatory factor 5 gene polymorphism in Egyptian children with systemic lupus erythematosus","volume":"26","author":"Hammad","year":"2017","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.berh.2024.101971_bib56","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1744-313X.2011.01025.x","article-title":"A meta-analysis of the association of IRF5 polymorphism with systemic lupus erythematosus","volume":"38","author":"Hu","year":"2011","journal-title":"Int J Immunogenet"},{"issue":"0","key":"10.1016\/j.berh.2024.101971_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15257770.2024.2325438","article-title":"Association of the polymorphisms rs179008 (TLR7), rs2004640 (IRF5), rs1800795 (IL-6) and rs2280788 (CCL5) with systemic lupus erythematosus in women of Mayan ethnicity from Yucatan","volume":"0","author":"Nakazawa-Ueji","year":"2024","journal-title":"Nucleos Nucleot Nucleic Acids"},{"issue":"2","key":"10.1016\/j.berh.2024.101971_bib58","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12016-010-8243-x","article-title":"Hydroxychloroquine: from malaria to autoimmunity","volume":"42","author":"Ben-Zvi","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.berh.2024.101971_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000437","article-title":"TNIP1\/ABIN1 and lupus nephritis: review","volume":"7","author":"Brady","year":"2020","journal-title":"Lupus Sci Med"},{"issue":"11","key":"10.1016\/j.berh.2024.101971_bib60","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1002\/art.34642","article-title":"Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus","volume":"64","author":"Adrianto","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.berh.2024.101971_bib61","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1177\/09612033221094706","article-title":"Assessment of the association between TNIP1 polymorphism with clinical features and risk of systemic lupus erythematosus","volume":"31","author":"Azhdari","year":"2022","journal-title":"Lupus"},{"issue":"11","key":"10.1016\/j.berh.2024.101971_bib62","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1681\/ASN.2013020148","article-title":"ABIN1 dysfunction as a genetic basis for lupus nephritis","volume":"24","author":"Caster","year":"2013","journal-title":"J Am Soc Nephrol JASN"},{"issue":"2","key":"10.1016\/j.berh.2024.101971_bib63","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ki.2014.270","article-title":"Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1","volume":"87","author":"Nichols","year":"2015","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.berh.2024.101971_bib64","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2215\/CJN.15161219","article-title":"APOL1 nephropathy: from genetics to clinical applications","volume":"16","author":"Friedman","year":"2021","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"6","key":"10.1016\/j.berh.2024.101971_bib65","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1177\/09612033231172660","article-title":"APOL1 and the risk of adverse renal outcomes in patients of African ancestry with systemic lupus erythematosus","volume":"32","author":"Chung","year":"2023","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.berh.2024.101971_bib66","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/art.38220","article-title":"End-stage renal disease in African Americans with lupus nephritis is associated with APOL1","volume":"66","author":"Freedman","year":"2014","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"R1","key":"10.1016\/j.berh.2024.101971_bib67","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1093\/hmg\/ddab024","article-title":"Kidney disease and APOL1","volume":"30","author":"Yusuf","year":"2021","journal-title":"Hum Mol Genet"},{"issue":"5993","key":"10.1016\/j.berh.2024.101971_bib68","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science."},{"issue":"20","key":"10.1016\/j.berh.2024.101971_bib69","doi-asserted-by":"crossref","first-page":"E2130","DOI":"10.1073\/pnas.1400699111","article-title":"Evolution of the primate trypanolytic factor APOL1","volume":"111","author":"Thomson","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.berh.2024.101971_bib70","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12859-020-3340-1","article-title":"LDpop: an interactive online tool to calculate and visualize geographic LD patterns","volume":"21","author":"Alexander","year":"2020","journal-title":"BMC Bioinf"},{"issue":"22","key":"10.1016\/j.berh.2024.101971_bib71","doi-asserted-by":"crossref","first-page":"19523","DOI":"10.1074\/jbc.M111.233916","article-title":"The human hyaluronan synthase 2 (HAS2) gene and its natural antisense RNA exhibit coordinated expression in the renal proximal tubular epithelial cell","volume":"286","author":"Michael","year":"2011","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.berh.2024.101971_bib72","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.ki.5000042","article-title":"Increased mesangial cell hyaluronan expression in lupus nephritis is mediated by anti-DNA antibody-induced IL-1beta","volume":"69","author":"Yung","year":"2006","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.berh.2024.101971_bib73","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1681\/ASN.2013050446","article-title":"Lupus nephritis susceptibility loci in women with systemic lupus erythematosus","volume":"25","author":"Chung","year":"2014","journal-title":"J Am Soc Nephrol JASN"},{"issue":"3","key":"10.1016\/j.berh.2024.101971_bib74","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2174\/157015911796557984","article-title":"Neuropsychiatric systemic lupus erythematosus","volume":"9","author":"Popescu","year":"2011","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"10.1016\/j.berh.2024.101971_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semarthrit.2010.08.001","article-title":"Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis","volume":"41","author":"Unterman","year":"2011","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.berh.2024.101971_bib76","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.autrev.2016.07.009","article-title":"The role of B cells and autoantibodies in neuropsychiatric lupus","volume":"15","author":"Wen","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.berh.2024.101971_bib77","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ajmg.a.36887","article-title":"Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1","volume":"167","author":"Crow","year":"2015","journal-title":"Am J Med Genet"},{"issue":"1","key":"10.1016\/j.berh.2024.101971_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4081\/reumatismo.2015.782","article-title":"Typing TREX1 gene in patients with systemic lupus erythematosus","volume":"67","author":"Fredi","year":"2015","journal-title":"Reumatismo"},{"issue":"7","key":"10.1016\/j.berh.2024.101971_bib79","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/jhg.2011.49","article-title":"Cumulative association of eight susceptibility genes with systemic lupus erythematosus in a Japanese female population","volume":"56","author":"Koga","year":"2011","journal-title":"J Hum Genet"},{"issue":"10","key":"10.1016\/j.berh.2024.101971_bib80","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrneurol.2014.148","article-title":"Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers","volume":"10","author":"Jeltsch-David","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"10.1016\/j.berh.2024.101971_bib81","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1177\/0961203312439335","article-title":"Standardization of antiphospholipid antibody assays. Where do we stand?","volume":"21","author":"Devreese","year":"2012","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.berh.2024.101971_bib82","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/rheumatology\/ker310","article-title":"Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients","volume":"51","author":"Govoni","year":"2012","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2024.101971_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102463","article-title":"A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus","volume":"19","author":"Choi","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.berh.2024.101971_bib84","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/art.38900","article-title":"Anti\u2013ribosomal P protein autoantibodies from patients with neuropsychiatric lupus impair memory in mice","volume":"67","author":"Bravo-Zehnder","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2024.101971_bib85","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12016-017-8627-2","article-title":"The cutaneous spectrum of lupus erythematosus","volume":"53","author":"Ribero","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.berh.2024.101971_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103262","article-title":"Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus","volume":"22","author":"Erazo-Mart\u00ednez","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2024.101971_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.07.007","article-title":"A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus","volume":"93","author":"Li","year":"2018","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.berh.2024.101971_bib88","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3390\/jcm9030712","article-title":"New horizons in the genetic etiology of systemic lupus erythematosus and lupus-like disease: monogenic lupus and beyond","volume":"9","author":"Demirkaya","year":"2020","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.berh.2024.101971_bib89","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.immuni.2013.08.004","article-title":"Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing","volume":"39","author":"Gehrke","year":"2013","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.berh.2024.101971_bib90","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jid.2021.04.037","article-title":"Photosensitivity and cGAS-dependent IFN-1 activation in patients with lupus and TREX1 deficiency","volume":"142","author":"Berndt","year":"2022","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.berh.2024.101971_bib91","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/annrheumdis-2016-209841","article-title":"Familial chilblain lupus due to a gain-of-function mutation in STING","volume":"76","author":"K\u00f6nig","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.berh.2024.101971_bib92","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.3390\/jcm10102218","article-title":"Asymptomatic carotid atherosclerosis cardiovascular risk factors and common hypertriglyceridemia genetic variants in patients with systemic erythematosus lupus","volume":"10","author":"Fanlo-Maresma","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.berh.2024.101971_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102863","article-title":"Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus","volume":"132","author":"Liu","year":"2022","journal-title":"J Autoimmun"},{"issue":"7","key":"10.1016\/j.berh.2024.101971_bib94","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1136\/annrheumdis-2017-212614","article-title":"Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis","volume":"77","author":"Leonard","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2024.101971_bib95","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ng.71","article-title":"A nonsynonymous functional variant in integrin-\u03b1M (encoded by ITGAM) is associated with systemic lupus erythematosus","volume":"40","author":"Nath","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.berh.2024.101971_bib96","article-title":"Musculoskeletal manifestations of systemic lupus erythematosus","volume":"22","author":"Shumilova","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"13","key":"10.1016\/j.berh.2024.101971_bib97","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1177\/09612033211051637","article-title":"Erosive arthritis in systemic lupus erythematosus: not only Rhupus","volume":"30","author":"Ceccarelli","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2024.101971_bib98","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/745647","article-title":"Genetic factors in systemic lupus erythematosus: contribution to disease phenotype","volume":"2015","author":"Ceccarelli","year":"2015","journal-title":"J Immunol Res"},{"issue":"1","key":"10.1016\/j.berh.2024.101971_bib99","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cei.13585","article-title":"Arthritis in systemic lupus erythematosus is characterized by local IL\u201017A and IL\u20106 expression in synovial fluid","volume":"205","author":"Sippl","year":"2021","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"10.1016\/j.berh.2024.101971_bib100","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1177\/0961203313500549","article-title":"Vitamin D receptor (VDR) gene polymorphisms and susceptibility to systemic lupus erythematosus clinical manifestations","volume":"22","author":"Silva","year":"2013","journal-title":"Lupus"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694224000421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694224000421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T02:04:24Z","timestamp":1732932264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694224000421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1521694224000421"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2024.101971","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the contribution of genetics on the clinical manifestations of systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2024.101971","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101971"}}